The benefits and limitations of sentinel lymph node biopsy

Current Treatment Options in Oncology

Volumn 7, Issue 2, 2006, Pages 141-151

  Amersi, Farin ^b   Hansen, Nora M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RADIOACTIVE MATERIAL;

ADVANCED CANCER; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MINIMALLY INVASIVE SURGERY; MORBIDITY; PAGET NIPPLE DISEASE; PALPATION; PATHOLOGIST; PREGNANCY; PROGNOSIS; REVIEW; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SURGICAL APPROACH; TISSUE SECTION; TREATMENT PLANNING; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SENTINEL LYMPH NODE BIOPSY;

EID: 33644552781     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-006-0049-y     Document Type: Review

References (75)

1. Cancer Facts and Figures 2005. Atlanta, GA. American Cancer Society; 2005.
2. Veronesi U, Cascinelli N, Mariani L, et al.: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.
3. Carter CL, Allen C, Henson DE, et al.: Relation of tumor size, lymph node status, and survival in 24,270 breast cancer cases. Cancer 1989, 63:181-187.
4. Beenken SW, Urist MM, Zhang Y, et al.: Axillary lymph node status, but not tumor size predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg 2003, 237:732-738.
5. Schijven MP, Vingerhoets AJ, Rutten HJ, et al.: Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003, 29:341-350.
6. Fortin A, Larochelle M, Laverdiere J, et al.: Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 1999, 17:101-109.
7. Huston TL, Simmons RM: Locally recurrent breast cancer after conservation therapy. Am J Surg 2005, 189:229-235.
8. Kissin MW, Querci della Rovera G, Easton D, et al.: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986, 73:580-584.
9. Keramopolous A, Tsionou C, Minaretzis D, et al.: Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 1993, 50:445-449.
10. Petrek JA, Senie RT, Peters M, Rosen PP: Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001, 92:1368-1377.
11. Burak WE, Hollenbeck ST, Zervos EE, et al.: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002, 183:23-27.
12. Swenson KK, Nissen MJ, Ceronsky C, et al.: Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002, 9:745-753.
13. Schijven MP, Vingerhoets AJ, Rutten HJ, et al.: Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003, 29:341-350.
14. Morton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
15. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994, 220:391-398.
16. Giuliano AE, Dale PS, Turner RR, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995, 222:394-401.
17. Krag DN, Weaver DL, Alex JC, et al.: Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe. Surg Oncol 1993, 2:335-340.
18. Veronesi U, Paganelli G, Galimberti V, et al.: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997, 349:1864-1867.
19. Krag D, Weaver D, Ashikaga T, et al.: The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998, 339:941-946.
20. McMasters KM, Wong SL, Tuttle TM, et al.: Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000, 231:724-731.
21. Miltenberg DM, Miller C, Karamlou TB, Brunicardi FC: Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999, 84:138-142.
22. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997, 15:2345-2350.
23. McMasters KM, Tuttle TM, Carlson DJ, et al.: Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000, 18:2560-2566.
24. Veronesi U, Paganelli G, Viale G, et al.: A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553.
25. Ernster VL, Barclay J: Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Manogr 1997, 22:151-156.
26. Ernster VL, Ballard-Barbash R, Barlow WE, et al.: Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002, 94:1546-1554.
27. Wilke C, White L, Dupont E, et al.: An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 2005, 190:563-566.
28. Kell M, Morrow M: An adequate margin of excision in ductal carcinoma in situ. BMJ 2005, 331:789-790.
29. Solin LJ, Fourquet A, Vicini FA: Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005, 103:1137-1146.
30. Morrow M, Strom EA, Bassett LW, et al.: Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 2002, 52:277-300.
31. Hartmann LC, Schaid DJ, Woods JE, et al.: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999, 340:77-84.
32. Stefanek M, Hartmann L, Nelson W: Risk reduction mastectomy: clinical issues and research needs. J Natl Cancer Inst 2001, 93:1297-1306.
33. Dupont EL, Kuhn MA, McCann C, et al.: The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 2000, 180:277.
34. Fisher B, Anderson S, Bryant J, et al.: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
35. Haigh P, Hansen N, Qi K, et al.: Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 2000, 7:21-27.
36. Wong S, Edwards M, Chao C, et al.: The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 2002, 9:272-277.
37. Luini A, Galimberti V, Gatti G, et al.: The sentinel lymph node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Technology. Breast Cancer Res Treat 2005, 89:159-163.
38. Intra M, Trifiro G, Viale G, et al.: Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy. Ann Surg Oncol 2005, 12:895-899.
39. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,470 breast cancer cases. Cancer 1989, 63:181-197.
40. Trudeau M, Sinclair SE, Clemons M, et al.: Neoadjuvant taxanes in the treatment of non-metastatic breast cancer. a systematic review. Cancer Treat Rev 2005, 31:283-302.
41. Mauriac L, MacGrogan G, Avril A, et al.: Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Ann Oncol 1999, 10:47-52.
42. Perloff M, Lesnick A, Korzun F, et al.: Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol 1988, 6:261-269.
43. Scholl SM, Fourquet B, Asselain JY, et al.: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: preliminary results of a randomized trial. Eur J Cancer 1994, 30:645-652.
44. DeLena M, Varini M, Zucali D, et al.: Multimodal treatment for locally advanced breast cancer. Results of chemotherapy-radiotherapy versus chemotherapy-surgery. Cancer Clin Trials 1981, 4:229-236.
45. Fisher B, Brown A, Mamounas A, et al.: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997, 15:2483-2493.
46. Abrial C, Van Praagh I, Delva R, et al.: Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer. Oncologist 2005, 10:242-249.
47. Pu RT, Schott AF, Sturtz DE, et al.: Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: importance of tumor necrosis. Am J Surg Pathol 2005, 29:354-358.
48. Rajan R, Esteva FJ, Symmans WF: Pathologic changes in breast cancer following neoadjuvant chemotherapy: implications for the assessment of response. Clin Breast Cancer 2004, 5:235-238.
49. Mamounas E: Sentinel node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 2003, 83:931-942.
50. Julian TB, Patel N, Dusi D, et al.: Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001, 182:407-410.
51. O'Hea BJ, Hill AD, El-Shirbiny AM, et al.: Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998, 186:423-427.
52. Tafra L, Verbanac KM, Lannin DR: Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 2001, 182:312-315.
53. Hsueh E, Hansen N, Giuliano AE: Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer. CA J Clin 2000, 50:279-291.
54. Veronesi U, Paganelli G, Galimberti V, et al.: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative nodes. Lancet 1997, 349:1864-1867.
55. Guenther JM, Krishnamoorthy M, Tan LR, eT al.: Sentinel lymphadectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997, 3:336-340.
56. Linehan D, Hill ADK, Akhurst T, et al.: Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol 1999, 6:450-454.
57. Rahusen F, Pijpers R, van Diest PJ, et al.: The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery 2000, 128:6-12.
58. Borgstein P, Meijer S, Pijpers RJ, et al.: Functional lymphatic anatomy for sentinel node biopsy in breast cancer. Ann Surg 2000, 232:81-89.
59. Giuliano AE, Jones RC, Brennan M, et al.: Sentinel lymphadectomy in breast cancer. J Clin Oncol 1997, 15:2345-2350.
60. Bedrosian I, Reynolds C, Mick R, et al.: Accuracy of sentinel lymph nodded biopsy in patients with large primary breast tumors. Cancer 2000, 88:2540-2545.
61. Greco M, Agresti R, Cascinelli N, et al.: Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. Ann Surg 2000, 232:1-7.
62. Ferno M: Prognostic factors in breast cancer: a brief review. Anticancer Res 1998, 18:2167-2171.
63. Chung MH, Ye W, Giuliano AE: Role for sentinel lymph node dissection in the management of large (> 5cm) invasive breast cancer. Ann Surg Oncol 2001, 8:688-692.
64. Gentilini O, Masullo M, Rotmensz N, et al.: Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Eur J Surg 2005, 31:232-236.
65. Keleher A, Wendt R, Delpassand E, et al.: The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 2004, 10:492-495.
66. Cserni G: The impact of axillary lymphadenopathy on further treatment in breast cancer? A model for clinical staging. Pathol Oncol Res 1998, 4:301-303.
67. Specht MC, Fey JV, Borgen PI, Cody HS: Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg 2005, 200:10-14.
68. Nason KS, Anderson BO, Byrd DR, et al.: Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000, 89:2187-2194.
69. Breslin TM, Cohen L, Sahin A, et al.: Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000, 18:3480-3486.
70. Stearns V, Ewing CA, Slack R, et al.: Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002, 9:235-242.
71. Fernandez A, Cortes M, Benito E, et al.: Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 2001, 22:361-366.
72. Haid A, Tausch C, Lang A, et al.: Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001, 92:1080-1084.
73. Reitsamer R, Peintinger F, Rettenbacher L, et al.: Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 2003, 84:63-67.
74. Miller AR, Thomason VE, Yeh IT, et al.: Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 2002, 9:243-247.
75. Piato JR, Barros AC, Pincerato KM, et al.: Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 2003, 29:118-120.